Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Elevated soluble CD14 receptors and altered cytokines in chronic heart failure.

Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ.

Am J Cardiol. 1997 May 15;79(10):1426-30.

PMID:
9165177
2.

Plasma cytokine parameters and mortality in patients with chronic heart failure.

Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD.

Circulation. 2000 Dec 19;102(25):3060-7.

3.

Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease.

Sharma R, Bolger AP, Li W, Davlouros PA, Volk HD, Poole-Wilson PA, Coats AJ, Gatzoulis MA, Anker SD.

Am J Cardiol. 2003 Jul 15;92(2):188-93.

PMID:
12860222
4.

Circulating levels of cytokines and their site of production in patients with mild to severe chronic heart failure.

Petretta M, Condorelli GL, Spinelli L, Scopacasa F, de Caterina M, Leosco D, Vicario ML, Bonaduce D.

Am Heart J. 2000 Dec;140(6):E28.

PMID:
11100001
5.
6.

Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria.

Akanmori BD, Kurtzhals JA, Goka BQ, Adabayeri V, Ofori MF, Nkrumah FK, Behr C, Hviid L.

Eur Cytokine Netw. 2000 Mar;11(1):113-8.

PMID:
10705308
7.

Type D personality is associated with increased levels of tumour necrosis factor (TNF)-alpha and TNF-alpha receptors in chronic heart failure.

Conraads VM, Denollet J, De Clerck LS, Stevens WJ, Bridts C, Vrints CJ.

Int J Cardiol. 2006 Oct 26;113(1):34-8. Epub 2005 Dec 1.

PMID:
16325284
8.

Change in circulating cytokines after 2 forms of exercise training in chronic stable heart failure.

LeMaitre JP, Harris S, Fox KA, Denvir M.

Am Heart J. 2004 Jan;147(1):100-5.

PMID:
14691426
9.

High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni.

Mwatha JK, Kimani G, Kamau T, Mbugua GG, Ouma JH, Mumo J, Fulford AJ, Jones FM, Butterworth AE, Roberts MB, Dunne DW.

J Immunol. 1998 Feb 15;160(4):1992-9.

10.

Adhesion molecules as a prognostic marker of liver cirrhosis.

Girón-González JA, Martínez-Sierra C, Rodriguez-Ramos C, Rendón P, Macías MA, Fernández-Gutiérrez C, Díaz F, Martín-Herrera L.

Scand J Gastroenterol. 2005 Feb;40(2):217-24.

PMID:
15764154
11.

Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.

Albillos A, de la Hera A, González M, Moya JL, Calleja JL, Monserrat J, Ruiz-del-Arbol L, Alvarez-Mon M.

Hepatology. 2003 Jan;37(1):208-17.

PMID:
12500206
12.

Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.

Koller-Strametz J, Pacher R, Frey B, Kos T, Woloszczuk W, Stanek B.

J Heart Lung Transplant. 1998 Apr;17(4):356-62.

PMID:
9588580
13.

Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure.

Genth-Zotz S, von Haehling S, Bolger AP, Kalra PR, Wensel R, Coats AJ, Anker SD.

Am J Cardiol. 2002 Dec 1;90(11):1226-30.

PMID:
12450603
14.

Inflammatory cytokines and the possible immunological role for lipoproteins in chronic heart failure.

Rauchhaus M, Koloczek V, Volk H, Kemp M, Niebauer J, Francis DP, Coats AJ, Anker SD.

Int J Cardiol. 2000 Nov-Dec;76(2-3):125-33.

PMID:
11104867
15.

Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure.

Lommi J, Pulkki K, Koskinen P, Näveri H, Leinonen H, Härkönen M, Kupari M.

Eur Heart J. 1997 Oct;18(10):1620-5.

16.

Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease.

Urbaschek R, McCuskey RS, Rudi V, Becker KP, Stickel F, Urbaschek B, Seitz HK.

Alcohol Clin Exp Res. 2001 Feb;25(2):261-8.

PMID:
11236841
17.

Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight.

Clark AL, Loebe M, Potapov EV, Egerer K, Knosalla C, Hetzer R, Anker SD.

Eur Heart J. 2001 Dec;22(24):2275-83.

18.

[Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmapheresis].

Tesar V, Jelínková E, Jirsa M Jr, Bakosová N, Pit'ha V, Chábová V.

Cas Lek Cesk. 1998 Nov 2;137(21):654-9. Czech.

PMID:
9929930
19.

Soluble CD14 (sCD14) levels in patients with multiple organ failure (MOF).

Endo S, Inada K, Kasai T, Takakuwa T, Nakae H, Kikuchi M, Yamashita H, Yoshida M.

Res Commun Chem Pathol Pharmacol. 1994 Apr;84(1):17-25.

PMID:
7518965
20.

The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure.

Genth-Zotz S, von Haehling S, Bolger AP, Kalra PR, Wensel R, Coats AJ, Volk HD, Anker SD.

Eur J Heart Fail. 2006 Jun;8(4):366-72. Epub 2005 Dec 5.

Items per page

Supplemental Content

Write to the Help Desk